Search

Displaying results 1061 - 1070 of 10000 in total
  1. Drug

    Triazolam

    go.drugbank.com/drugs/DB00897
    ApprovedInvestigational

    Withdrawn in the United Kingdom due to risk of psychiatric adverse drug reactions. This drug continues to be available in the U.S. … Internationally, triazolam is a Schedule IV drug under the Convention on Psychotropic Substances.

    Products: TRIAZOLAM EG, Halcion 0,25 mg - Tabletten
  2. Drug

    Mizolastine

    go.drugbank.com/drugs/DB12523
    Approved

    Mizolastine is under investigation in clinical trial NCT01928316 (A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers).

    Products: MIZOLEN 10 MG TABLETAS DE LIBERACION PROLONGADA
  3. Drug

    Influenza B virus B/Brisbane/60/2008 recombinant hemagglutinin antigen

    go.drugbank.com/drugs/DB14418
    ApprovedInvestigationalWithdrawn

    Inactivated virus cannot replicate, and therefore cannot cause disease from infection, even in immunocompromised individuals. … In contrast, live vaccines are produced from "wild-type" or disease-causing viruses that have been attenuated, or weakened, through various laboratory techniques.

    Synonyms: Influenza B virus B/Brisbane/60/2008 recombinant hemagglutinin antigen
  4. Drug

    Daptomycin

    go.drugbank.com/drugs/DB00080
    ApprovedInvestigational

    [A231379] Daptomycin was approved by the FDA on September 12, 2003, and is marketed under the name CUBICIN® by Cubist Pharmaceuticals LLC (Merck & Co.).[L32534] … [A231384] Early work on developing daptomycin was abandoned due to observed myopathy but was resumed in 1997 when Cubist Pharmaceuticals Inc. licensed daptomycin; it was found that a once-daily dosing

    Products: DAPTOMICINA DR. REDDY'S, Daptomycin in Sodium Chloride
  5. Drug

    Pentazocine

    go.drugbank.com/drugs/DB00652
    ApprovedVet approved

    It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)

    Products: Pentazocine-Fresenius 30 mg/ml injection, Talwin - Liq 30mg/ml
  6. Drug

    Tafamidis

    go.drugbank.com/drugs/DB11644
    ApprovedInvestigational

    [A189717] Tafamidis was granted an EMA market authorisation on 16 November 2011[L6247] and FDA approval on 3 May 2019.[L11280]

    Products: VYNDAQEL® 20 MG CAPSULABLANDA., Vyndaqel 20 mg Yumuşak Kapsül, 30 ADET
  7. Drug

    Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)

    go.drugbank.com/drugs/DB14444
    ApprovedInvestigationalWithdrawn

    Inactivated virus cannot replicate, and therefore cannot cause disease from infection, even in immunocompromised individuals. … In contrast, live vaccines are produced from "wild-type" or disease-causing viruses that have been attenuated, or weakened, through various laboratory techniques.

    Synonyms: Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated), Influenza a Virus A/california/7/2009(h1n1)-like Antigen (Propiolactone Inactivated)
  8. Drug

    Monensin

    go.drugbank.com/drugs/DB11430
    ExperimentalVet approved

    It is widely used in ruminant animal feeds.

    Categories: Compounds used in a research, industrial, or household settingProducts: Elancoban 200 Granulated Premix, 200g/kg, Coxidin® 200g/kg MicroGranulate Premix
  9. Drug

    Influenza A virus A/Uruguay/716/2007(H3N2) live (attenuated) antigen

    go.drugbank.com/drugs/DB14447
    ApprovedInvestigationalWithdrawn

    Inactivated virus cannot replicate, and therefore cannot cause disease from infection, even in immunocompromised individuals. … In contrast, live vaccines are produced from "wild-type" or disease-causing viruses that have been attenuated, or weakened, through various laboratory techniques.

    Synonyms: Influenza A virus A/Uruguay/716/2007(H3N2) live (attenuated) antigen, Influenza a Virus A/uruguay/716/2007(H3N2) Live(attenuated) Antigen
  10. Drug

    Rifampin

    go.drugbank.com/drugs/DB01045
    ApprovedInvestigational

    Rifampin, also known as rifampicin, is a broad-spectrum antimicrobial [A263748] that was first discovered in 1965 [A263753] and clinically used in 1968.

    Mixtures: RIFAMPICINA 300 MG + ISONIAZIDA 150 MG, RIFAMPICINA 300 MG + ISONIAZIDA 150 MGSynonyms: 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate